van Nimwegen, K.J., et al., Is the $1000 genome as near as we think? A cost analysis of next-generation sequencing. Clin Chem, 2016. 62(11): p. 1458-1464.
Lionel, A.C., et al., Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med, 2018. 20(4): p. 435-443.
Meng, L., et al., Use of exome sequencing for infants in intensive care units: Ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr, 2017. 171(12): p. e173438.
Willig, L.K., et al., Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respir Med, 2015. 3(5): p. 377-387.
Elliott, A.M., et al., RAPIDOMICS: rapid genomewide sequencing in a neonatal intensive care unit-successes and challenges. Eur J Pediatr, 2019. 178(8): p. 1207-1218.
Gubbels, C.S., et al., Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet Med, 2019.
Miller, N.A., et al., A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med, 2015. 7: p. 100.
Stark, Z., et al., Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med, 2017. 19(8): p. 867-874.
Stark, Z., et al., Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness. Genet Med, 2019. 21: p. 173-180.
Amendola, L.M., et al., Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet, 2016. 98(6): p. 1067-1076.
Bland, A., et al., Clinically impactful differences in variant interpretation between clinicians and testing laboratories: a single-center experience. Genet Med, 2018. 20(3): p. 369-373.
American Academy of Pediatrics and American College of Medical Genetics, Ethical and policy issues in genetic testing and screening of children. Pediatrics, 2013. 131(3): p. 620-622.
Botkin, J.R., et al., Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet, 2015. 97(1): p. 6-21.
Newson, A.J. and L. Schonstein, Genomic testing in the paediatric population: Ethical considerations in light of recent policy statements. Mol Diagn Ther, 2016. 20(5): p. 407-14.
Szego, M.J., et al., Views from the clinic: Healthcare provider perspectives on whole genome sequencing in paediatrics. Eur J Med Genet, 2019. 62(5): p. 350-356.
Knapp, B., C. Decker, and J.D. Lantos, Neonatologists’ attitudes about diagnostic whole-genome sequencing in the NICU. Pediatrics, 2019. 143(Suppl 1): p. S54-S57.
Stark, Z., et al., Attitudes of Australian health professionals towards rapid genomic testing in neonatal and paediatric intensive care. Eur J Hum Genet, 2019. 27(10): p. 1493-1501.